SCHEMBL19784360

SCHEMBL19784360

COC[C@@H](C)Oc1cc(NC(=O)N(C)c2ccc(CN3CCN(C)CC3O)c(C=O)n2)ncc1C#N

nearest known ligand 0.59

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ FGFR4 P22455 20/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23328613 0.87 FGFR4 (0.55) FGFR4
SCHEMBL21000258 0.87 FGFR4 (0.75) FGFR4
SCHEMBL29597029 0.87 FGFR4 (0.75) FGFR4
SCHEMBL19783874 0.87 FGFR4 (0.75) FGFR4
SCHEMBL22023347 0.87 FGFR4 (0.75) FGFR4
SCHEMBL20971315 0.85 FGFR4 (0.64) FGFR4
SCHEMBL22080154 0.84 FGFR4 (0.56) FGFR4
SCHEMBL27053883 0.82 FGFR4 (0.58) FGFR4
SCHEMBL23328597 0.82 FGFR4 (0.55) FGFR4
SCHEMBL21000343 0.82 FGFR4 (0.87) FGFR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3663285-A1 FORMYLPYRIDINE DERIVATIVE HAVING FGFR4 INHIBITORY ACTIVITY, PREPARATION METHOD THEREFOR AND USE THEREOF Abbisko Therapeutics Co., Ltd. (CN) 2020-06-10 — — EP disclosed
WO-2018010514-A1 HETEROCYCLIC COMPOUND USED AS FGFR INHIBITOR 南京天印健华医药科技有限公司 2018-01-18 — — WO disclosed
Send feedback